IBO (Impact BioMedical) Total Liabilities : $13.05 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Total Liabilities?

Impact BioMedical's Total Liabilities for the quarter that ended in Dec. 2024 was $13.05 Mil.

Impact BioMedical's quarterly Total Liabilities declined from Jun. 2024 ($17.73 Mil) to Sep. 2024 ($12.34 Mil) but then increased from Sep. 2024 ($12.34 Mil) to Dec. 2024 ($13.05 Mil).

Impact BioMedical's annual Total Liabilities increased from Dec. 2022 ($13.83 Mil) to Dec. 2023 ($16.37 Mil) but then declined from Dec. 2023 ($16.37 Mil) to Dec. 2024 ($13.05 Mil).

Impact BioMedical Total Liabilities Historical Data

The historical data trend for Impact BioMedical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Total Liabilities Chart

Impact BioMedical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

6.32

16.50

13.83

16.37

13.05

Impact BioMedical Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															16.37	17.09	17.73	12.34	13.05

Impact BioMedical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Impact BioMedical's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.785	+	(0	+	8.8817841970013E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	3.268	+	0	+	0)
	=	13.05

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	20.29	-	7.237
	=	13.05

Impact BioMedical's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.785	+	(0	+	8.8817841970013E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	3.268	+	0	+	0)
	=	13.05

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	20.29	-	7.237
	=	13.05

Impact BioMedical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Impact BioMedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084

Website

https://www.impactbiomedinc.com

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Impact BioMedical Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024